Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation

Braghieri, L., Jennings, D. L., Bohn, B., Habal, M., Pinsino, A., Mondellini, G. M., Ladanyi, A., Latif, F., Clerkin, K., Restaino, S., Kurlansky, P., Takeda, K., Naka, Y., Demmer, R. T., Sayer, G. T., Uriel, N., Colombo, P. C., & Yuzefpolskaya, M. (2022). Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 42(9), 697–706. Portico. https://doi.org/10.1002/phar.2724
Authors:
Lorenzo Braghieri
Douglas L Jennings
Bruno Bohn
Marlena Habal
Alberto Pinsino
Giulio M Mondellini
Annamaria Ladanyi
Farhana Latif
Kevin Clerkin
Susan Restaino
Paul Kurlansky
Koji Takeda
Yoshifumi Naka
Ryan T Demmer
Gabriel T Sayer
Nir Uriel
Paolo C Colombo
Melana Yuzefpolskaya
Affiliated Authors:
Lorenzo Braghieri
Douglas L Jennings
Marlena Habal
Alberto Pinsino
Giulio M Mondellini
Annamaria Ladanyi
Farhana Latif
Kevin Clerkin
Susan Restaino
Paul Kurlansky
Koji Takeda
Yoshifumi Naka
Ryan T Demmer
Gabriel T Sayer
Nir Uriel
Paolo C Colombo
Melana Yuzefpolskaya
Author Keywords:
acute cellular rejection
dysbiosis
glucuronidase
gut microbiome
heart transplant
mycophenolate mofetil
neutropenia
precision medicine
Publication Type:
Article
Unique ID:
10.1002/phar.2724
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: